ロード中...
The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
Glulisine (Apidra(®)) is a rapid-acting human insulin analog approved for use in children with diabetes mellitus ≥4 years of age. Management of children with type 1 diabetes has seen a shift in favor of mimicking normal physiological insulin responses with multiple daily injections or continuous sub...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047962/ https://ncbi.nlm.nih.gov/pubmed/21437110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSOTT.S5116 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|